This topic contains a solution. Click here to go to the answer

Author Question: Increasing the number of subtests that are added to create a composite score is equivalent to which ... (Read 35 times)

plus1

  • Hero Member
  • *****
  • Posts: 676
Increasing the number of subtests that are added to create a composite score is equivalent to which activity below?
 
  a. Increasing the number of items on a test
  b. Increasing the number of test-takers
  c. Increasing the testing time for a single test
  d. None of the above

Question 2

Differences in values may be at the heart of many consultee - consultant conflicts.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

C.mcnichol98

  • Sr. Member
  • ****
  • Posts: 314
Answer to Question 1

a

Answer to Question 2

T




plus1

  • Member
  • Posts: 676
Reply 2 on: Jul 31, 2018
Excellent


TheDev123

  • Member
  • Posts: 332
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

The human body's pharmacokinetics are quite varied. Our hair holds onto drugs longer than our urine, blood, or saliva. For example, alcohol can be detected in the hair for up to 90 days after it was consumed. The same is true for marijuana, cocaine, ecstasy, heroin, methamphetamine, and nicotine.

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

Did you know?

Fungal nail infections account for up to 30% of all skin infections. They affect 5% of the general population—mostly people over the age of 70.

Did you know?

The highest suicide rate in the United States is among people ages 65 years and older. Almost 15% of people in this age group commit suicide every year.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library